Page last updated: 2024-12-06

tetrazolium violet

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tetrazolium violet is a redox indicator that is commonly used in cell viability assays. It is a colorless compound that is reduced to a purple formazan dye by living cells, allowing for the quantification of cell proliferation and viability. The dye is typically used in conjunction with other dyes, such as MTT or XTT, to assess cell viability. Tetrazolium violet is a safe and reliable reagent for cell viability assays. It has been shown to be effective in a variety of cell types, including cancer cells, bacteria, and fungi. Tetrazolium violet is a widely used reagent in research and is particularly useful for studying cell proliferation, cell death, and drug efficacy. The compound is typically synthesized through a multi-step process that involves the reaction of aromatic amines with diazonium salts. The mechanism of action of tetrazolium violet involves the reduction of the tetrazolium ring by electron-donating molecules, such as NADH and NADPH, which are found in living cells. This reduction results in the formation of a purple formazan dye, which can be measured spectrophotometrically. The amount of formazan dye produced is directly proportional to the number of living cells in the sample. Tetrazolium violet is often used in conjunction with other assays, such as the MTT assay and the XTT assay, to assess cell viability. These assays are typically used to determine the cytotoxic effects of drugs, chemicals, or other agents on cells. Tetrazolium violet is a valuable tool for research in a variety of fields, including cancer biology, toxicology, and drug discovery.'

tetrazolium violet: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

tetrazolium violet : An organic chloride salt having tetrazolium violet(1+) as the counterion. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID74395
CHEMBL ID272093
CHEBI ID75193
SCHEMBL ID134943
MeSH IDM0524737

Synonyms (31)

Synonym
1719-71-7
nsc-89171
nsc89171
LS-14981
tetrazolium violet
tetrazolium purple
violet tetrazolium
einecs 217-008-7
nsc 89171
tv
2,5-diphenyl-3(1-naphthyl)-2h-tetrazolium chloride
2h-tetrazolium, 3-(1-naphthyl)-2,5-diphenyl-, chloride
T-2600
CHEMBL272093
chebi:75193 ,
FT-0654502
2,5-diphenyl-3-(1-naphthyl)tetrazolium chloride
T0174
3-(1-naphthyl)-2,5-diphenyl-2h-tetrazol-3-ium chloride
AKOS015896126
SCHEMBL134943
mfcd00011875
tetrazolium violet, >=94% (at)
3-(naphthalen-1-yl)-2,5-diphenyl-2h-tetrazol-3-ium chloride
Q27145161
104117-26-2
DTXSID70938063
AMY39290
D92314
CS-0135937
HY-131490
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
dyenull
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic chloride salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID317434Antimalarial activity against Plasmodium falciparum in LDH reporter assay2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
Anti-Plasmodium activity of tetrazolium salts.
AID735073Displacement of SYBR green I from salmon testes DNA assessed as compound treated with DNA followed by SYBR green I added relative to control2013Bioorganic & medicinal chemistry letters, Mar-01, Volume: 23, Issue:5
The interaction of imidazole-, imidazolium-, and tetrazolium-containing compounds with DNA.
AID317436Ratio of IC50 for CHO cells to IC50 for Plasmodium falciparum2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
Anti-Plasmodium activity of tetrazolium salts.
AID317435Toxicity in CHO cells2008Bioorganic & medicinal chemistry, Feb-15, Volume: 16, Issue:4
Anti-Plasmodium activity of tetrazolium salts.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.93 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]